{"id":192,"date":"2011-02-08T09:52:37","date_gmt":"2011-02-08T14:52:37","guid":{"rendered":"https:\/\/www.bu.edu\/nf-kb\/?page_id=192"},"modified":"2026-06-25T07:44:16","modified_gmt":"2026-06-25T11:44:16","slug":"gilmore-lab-publications","status":"publish","type":"page","link":"https:\/\/www.bu.edu\/nf-kb\/the-gilmore-lab\/gilmore-lab-publications\/","title":{"rendered":"Gilmore Lab Publications"},"content":{"rendered":"

 <\/p>\n\n\n\n
1. Radke K, T Gilmore<\/strong>, GS Martin. 1980. Phosphorylation of a 36,000 molecular weight cellular polypeptide in Rous sarcoma virus-transformed fibroblasts. In, Protein Phosphorylation and Bio-Regulation<\/em> (eds. G Thomas, E Podesta, and J Gordon), S Karger, Basel, Switzerland, pp 186-192.<\/p>\n

2.Radke K, T Gilmore,<\/strong>\u00a0GS Martin. 1980. Transformation by Rous sarcoma virus: a cellular substrate for transformation-specific phosphorylation contains phosphotyrosine. Cell 21 :821-828.\u00a0 (Abstract Link)
\n<\/a><\/p>\n

3.Pawson T, J Guyden, T-H Kung, K Radke, T Gilmore<\/strong>, GS Martin. 1980. A strain of Fujinami sarcoma virus which is temperature-sensitive in protein phosphorylation and cellular transformation. Cell 22: 767-775. (Abstract Link)
\n<\/a><\/p>\n

4.Gilmore T<\/strong>, K Radke, GS Martin. 1982. Tyrosine phosphorylation of a 50K cellular polypeptide associated with the Rous sarcoma virus transforming protein, pp60src. Molecular and Cellular Biology 2: 199-206. (Abstract Link)
\n<\/a><\/p>\n

5.Gilmore T,<\/strong>\u00a0GS Martin. 1983. Phorbol ester and diacylglycerol induce protein phosphorylation at tyrosine. Nature 306: 487-490. (Abstract Link)
\n<\/a><\/p>\n

6.Martin GS, K Radke, C Carter, P Moss, P Dehazya, T Gilmore<\/strong>. 1984. The role of protein phosphorylation at tyrosine in transformation and mitogenesis. Cold Spring Harbor Conference on Cell Proliferation and Cancer. Journal of Cell Physiology Supplement 3: 139-149.\u00a0(Abstract Link)
\n<\/a><\/p>\n

7.Moss P, K Radke, V Carter, J Young, T Gilmore<\/strong>, GS Martin. 1984. Cellular localization of the transforming protein of wild-type and temperature-sensitive Fujinami sarcoma virus. Journal of Virology 52: 557-565. (Abstract Link)
\n<\/a><\/p>\n

8.Gilmore T,<\/strong> J DeClue, GS Martin. 1985. Tyrosine kinase activity associated with the v-erbB gene product.\u00a0 In, The Cancer Cell (eds. G Ferramisco, B Ozanne, and C Stiles) Volume 3: 25-32.<\/p>\n

9.Gilmore TD<\/strong>, J DeClue , GS Martin. 1985. Protein phosphorylation at tyrosine is induced by the v-erbB gene product in vivo and in vitro. Cell 40: 609-618. (Abstract Link)
\n<\/a><\/p>\n

10.Gilmore TD,<\/strong>\u00a0HM Temin. 1986. Different localization of the product of the v-rel oncogene in chicken fibroblasts and spleen cells correlates with transformation by REV-T. Cell 44: 791-800. (Abstract Link)
\n<\/a><\/p>\n

11.Luk K-C, T Gilmore,<\/strong>\u00a0A Panganiban. 1987. The spleen necrosis virus int gene product expressed in Escherichia coli has DNA binding activity and mediates att and U5-specific multimer formation in vitro. Virology 57: 127-136. (Abstract Link)
\n<\/a><\/p>\n

12.Gilmore TD,<\/strong>\u00a0HM Temin. 1988. v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells. Journal of Virology 62: 703-714. (Abstract Link)
\n<\/a><\/p>\n

13.Capobianco A, DL Simmons, TD Gilmore<\/strong>. 1990. Cloning and expression of a chicken c-rel cDNA:\u00a0 unlike p59v-rel, p68c-rel is a cytoplasmic protein in chicken embryo fibroblasts. Oncogene 5: 257-266. (Abstract Link)
\n<\/a><\/p>\n

14.Delwart EL, G Mosialos, T Gilmore<\/strong>. 1990. Retroviral envelope glycoproteins contain a “leucine zipper”-like repeat. AIDS Research and Human Retroviruses 6: 703-706. (Abstract Link)
\n<\/a><\/p>\n

15.Kamens J, P Richardson, G Mosialos, R Brent, TD Gilmore<\/strong>. 1990. Oncogenic transformation by vRel requires an amino-terminal activation domain. Molecular and Cellular Biology 10: 2840-2847. (Abstract Link)
\n<\/a><\/p>\n

16.Gilmore TD<\/strong>. 1990. NF-kB, KBF1, dorsal, and rel<\/em>ated matters. Cell 62: 841-843. (Abstract Link)
\n<\/a><\/p>\n

17.Dailey D, GL Schieven, MY Lim, T Gilmore<\/strong>, J Thorner, GS Martin. 1990. Novel yeast protein kinase (YPK1 gene product) is a 40-kilodalton phosphotyrosyl protein associated with protein-tyrosine kinase activity. Molecular and Cellular Biology 10: 6244-6256. (Abstract Link)
\n<\/a><\/p>\n

18.Richardson PM, TD Gilmore.<\/strong> 1991. vRel is an inactive member of the Rel family of transcriptional activating proteins. Journal of Virology 65: 3122-3130. (Abstract Link)
\n<\/a><\/p>\n

19.Gilmore TD<\/strong>. 1991. Malignant transformation by mutant Rel proteins. Trends in Genetics 7: 318-322. (Abstract Link)
\n<\/a><\/p>\n

20.Mosialos G, P Hamer, AJ Capobianco, R Laursen, TD Gilmore<\/strong>. 1991. A protein kinase A recognition sequence is structurally linked to transformation by p59v-rel and cytoplasmic retention of p68c-rel. Molecular and Cellular Biology 11: 5867-5877. (Abstract Link)
\n<\/a><\/p>\n

21.Capobianco A, TD Gilmore<\/strong>. 1991. Repression of the chicken c-rel promoter by vRel in chicken embryo fibroblasts is not mediated through a consensus NF-kB binding site. Oncogene 6: 2203-2210. (Abstract Link)
\n<\/a><\/p>\n

22.Morin P, TD Gilmore<\/strong>. 1992. The C terminus of the NF-kB p50 precursor protein and an IkB isoform contain transcription activation domains. Nucleic Acids Research 20: 2453-2458.(Abstract Link)<\/a>
\n<\/a><\/p>\n

23.Capobianco AJ, D Chang, G Mosialos, TD Gilmore<\/strong>. 1992. p105, the NF-kB p50 precursor, is one of the cellular proteins complexed with the v-Rel oncoprotein in transformed chicken cells. Journal of Virology 66: 3758-3767. (Abstract Link)<\/a>
\n<\/a><\/p>\n

24.Gilmore TD<\/strong>. 1992. Role of rel<\/em> family genes in normal and malignant lymphoid cell growth. Cancer Surveys 15: 69-87. (Abstract Link)<\/a>
\n<\/a><\/p>\n

25.Morin PJ, G Subramanian, TD Gilmore<\/strong>. 1992. AAT1<\/em>, a gene encoding a mitochondrial aspartate aminotransferase in Saccharomyces cerevisiae<\/em>. Biochimica et Biophysica Acta 1171: 211-214. (Abstract Link)<\/a>
\n<\/a><\/p>\n

26.Mosialos G, TD Gilmore<\/strong>. 1993. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence. Oncogene 8 :721-730. (Abstract Link)<\/a>
\n<\/a><\/p>\n

27.Capobianco AJ, TD Gilmore<\/strong>. 1993. A conditional mutant of vRel containing sequences from the human estrogen receptor. Virology 193:1 60-170. (Abstract Link)
\n<\/a><\/p>\n

28.Morin PJ, GS Subramanian, TD Gilmore<\/strong>. 1993. GAL4-IkBa and GAL4-IkBg activate transcription by different mechanisms. Nucleic Acids Research 21: 2157-2163. (Abstract Link)
\n<\/a><\/p>\n

29.Sarkar S, TD Gilmore<\/strong>. 1993. Transformation by the vRel oncoprotein requires sequences carboxy-terminal to the Rel homology domain. Oncogene 8: 2245-2252. (Abstract Link)
\n<\/a><\/p>\n

30.Sif S, AJ Capobianco & TD Gilmore. 1993. The v-Rel oncoprotein increases expression from Sp1 site-containing promoters in chicken embryo fibroblasts. Oncogene 8: 2501-2509. (Abstract Link)
\n<\/a><\/p>\n

31.White DW & TD Gilmore. 1993. Temperature-sensitive transforming mutants of the v-rel<\/em> oncogene. Journal of Virology 67: 6876-6881. (Abstract Link)
\n<\/a><\/p>\n

32.Sif S & TD Gilmore. 1993. NF-kB p100 is one of the high-molecular-weight proteins associated with the v-Rel oncoprotein in transformed chicken spleen cells. Journal of Virology 67: 7612-7617. (Abstract Link)
\n<\/a><\/p>\n

33.Gilmore TD & PJ Morin. 1993. The IkB proteins:\u00a0 members of a multifunctional family. Trends in Genetics 9: 427-433. (Abstract Link)<\/a>
\n<\/a><\/p>\n

34.Feinstein R, WK Bolton, JN Quinones, G Mosialos, S Sif, JL Huff, AJ Capobianco & TD Gilmore. 1994. Characterization of a chicken cDNA encoding the retinoblastoma gene product. Biochimica et Biophysica Acta 1218: 82-86. (Abstract Link)
\n<\/a><\/p>\n

35.Sif S & TD Gilmore. 1994. Interaction of the v-Rel oncoprotein with cellular transcription factor Sp1. Journal of Virology 68: 7131-7138.\u00a0 (Abstract Link)<\/a><\/p>\n

36.White DW, A Roy & TD Gilmore. 1995. The v-Rel oncoprotein blocks apoptosis and proteolysis of IkB-a in transformed chicken spleen cells. Oncogene 10: 857-868. (Abstract Link)<\/a><\/p>\n

37.Gilmore TD, DW White, S Sarkar & S Sif. 1995. Malignant transformation of cells by the v-Rel oncoprotein. In, The DNA Provirus:\u00a0 Howard Temin’s Scientific Legacy<\/em> (eds. GM Cooper, R Greenberg Temin, and B Sugden), American Society for Microbiology, Washington D.C., pp 109-128.<\/p>\n

38.Morin PJ, J Downs, AM Snodgrass & TD Gilmore. 1995. Genetic analysis of growth inhibition by GAL4-IkB-a in Saccharomyces cerevisiae. Cell Growth & Differentiation 6: 789-798. (Abstract Link)<\/a><\/p>\n

39.Gilmore TD. 1995. Regulation of Rel transcription complexes.\u00a0 In, Frontiers in Molecular Biology: Eukaryotic Gene Transcription<\/em> (ed. S Goodbourn), Oxford University Press, Oxford, England, pp 102-131.<\/p>\n

40.White DW, GA Pitoc & TD Gilmore. 1996. Interaction of the v-Rel oncoprotein with NF-kB and IkB proteins:\u00a0 heterodimers of a transformation-defective v-Rel mutant and NF-kB p52 are functional in vitro and in vivo. Molecular and Cellular Biology 16: 1169-1178. (Abstract Link)<\/a><\/p>\n

41.White DW & TD Gilmore. 1996. Bcl-2 and CrmA have different effects on transformation, apoptosis, and the stability of IkB-a in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins. Oncogene 13: 891-899. (Abstract Link)<\/a><\/p>\n

42.Gilmore TD, M Koedood, KA Piffat & DW White. 1996. Rel\/NF-kB\/IkB proteins and cancer. Oncogene 13:1367-1378. (Abstract Link)<\/a><\/p>\n

43.Gilmore TD (editor). 1997. Rel\/NF-kB. Seminars in Cancer Biology, Academic Press, Cambridge, England. Volume 8-2, pp 61-129.<\/p>\n

44.Barkett M, D Xue, HR Horvitz & TD Gilmore. 1997. Phosphorylation of IkB-a inhibits its cleavage by caspase CPP32 in vitro. Journal of Biological Chemistry 272: 29419-29422. (Abstract Link)<\/a><\/p>\n

45.Gilmore TD. 1997. Clinically rel<\/em>evant findings. Journal of Clinical Investigation 100: 2935-2936. (Abstract Link)<\/a><\/p>\n

46.Sylla B, SC Hung, DM Davidson, E Hatzivassiliou, NL Malinin, D Wallach, TD Gilmore, E Kieff & G Mosialos. 1998. Epstein-Barr virus transforming protein latent infection membrane protein 1 activates transcription factor NF-kB through a pathway that includes the NF-kB-inducing kinase and the IkB kinases IKKa and IKKb. Proceedings of the National Academy of Sciences USA 95: 10106-10111. (Abstract Link)<\/a><\/p>\n

47.Wang Y, JE Dooher, M Koedood Zhao & TD Gilmore. 1999. Characterization of mouse Trip6: a putative intracellular signaling protein. Gene 234: 403-409. (Abstract Link)<\/a><\/p>\n

48.Epinat J-C & Gilmore TD. 1999. In vitro-translated diphtheria toxin A chain inhibits translation in wheat germ extracts: analysis of biologically active, caspase-3-resistant diphtheria toxin mutants. Biochimica et Biophysica Acta 1472: 34-41. (Abstract Link)<\/a><\/p>\n

49.Gilmore TD, J-C Epinat & M Barkett. 1999. Misregulation of a signal transduction pathway: role of Rel\/NF-kB transcription factors in oncogenesis. In, DNA Alterations in Cancer: Genetic and Epigenetic Changes (ed. M Ehrlich), BioTechniques Books, Eaton Publishing, Natick, MA, USA. pp 121-136.<\/p>\n

50. Koedood Zhao M, Y Wang, K Murphy, J Yi, MC Beckerle & TD Gilmore. 1999. LIM domain-containing protein Trip6 can act as a co-activator for the v-Rel transcription factor. Gene Expression 8: 207-217. (Abstract Link)<\/a><\/p>\n

51. Gilmore TD. 1999. The Rel\/NF-kB signal transduction pathway: introduction. Oncogene 18: 6842-6844. (Abstract Link)<\/a><\/p>\n

52. Epinat J-C & TD Gilmore. 1999. A variety of agents can act at multiple levels to inhibit the Rel\/NF-kB signal transduction pathway. Oncogene 18: 6896-6909. (Abstract Link)<\/a><\/p>\n

53. Barkett M & TD Gilmore. 1999.\u00a0 Control of apoptosis by Rel\/NF-kB\u00a0 transcription factors. Oncogene 18: 6910-6924. (Abstract Link)<\/a><\/p>\n

54. Gilmore TD. 1999. Multiple mutations contribute to the oncogenicity of\u00a0 the retroviral oncoprotein v-Rel. Oncogene 18: 6925-6937. (Abstract Link)<\/a><\/p>\n

55. Epinat J-C, D Kazandjian, DD Harkness, S Petros, J Dave, DW White & TD Gilmore. 2000. Mutant Envelope residues confer a transactivation function onto N-terminal sequences of the v-Rel oncoprotein. Oncogene 19: 599-607. (Abstract Link)<\/a> (Data-link)<\/a><\/p>\n

56. Epinat J-C, EL Dvorin & TD Gilmore. 2000. Envelope-dependent transactivation by the retroviral oncoprotein v-Rel is required for efficient\u00a0 transformation of chicken spleen cells. Oncogene 19: 3131-3137.\u00a0 (Abstract Link)<\/a> (Data-link 1<\/a>)<\/p>\n

57. Barkett M, JE Dooher, L Lemonnier, L Simmons, JN Scarpati, Y Wang & TD Gilmore. 2001. Three mutations in the retroviral oncoprotein v-Rel render it resistant to cleavage by caspase-3. Biochimica et Biophysica Acta 1526: 25-36. (Abstract Link)<\/a> (Data-link 2<\/a>)<\/p>\n

58. Wang Y & TD Gilmore. 2001. LIM domain protein Trip6 has a conserved nuclear export signal, nuclear targeting sequences, and multiple transactivation domains. Biochimica et Biophysica Acta 1538: 260-272. (Abstract Link)<\/a><\/p>\n

59. Piffat KA,\u00a0 R Hrdlickova,\u00a0 J Nehyba, T Ikeda, A Liss, S Huang, S Sif, TD Gilmore & HR Bose Jr. 2001. The chicken RelB transcription factor has transactivation sequences and a tissue-specific expression pattern that are distinct from mammalian RelB. Molecular Cell Biology Research Communications 4: 266-275. (Abstract Link)<\/a> (Data-link 3<\/a>)<\/p>\n

60. Gilmore TD, C Cormier, J Jean-Jacques & M-E Gapuzan. 2001. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel. Oncogene 20: 7098-7103. (Abstract Link)<\/a> (Data-link 4<\/a>)<\/p>\n

61.Li C, EA Pace, M-C Liang, E Lobkovsky, TD Gilmore & JA Porco Jr. 2001. Total synthesis of the NF-kB inhibitor (-)-cycloepoxydon: utilization of tartrate-mediated nucleophilic epoxidation. Journal of the American Chemical Society 123: 11308-11309.\u00a0 (Abstract Link)<\/a><\/p>\n

62.Gilmore TD, M-E Gapuzan, D Kalaitzidis & D Starczynowski. 2002. Rel\/NF-kB\/IkB signal transduction in the generation and treatment of human cancer. Cancer Letters 181 :1-9. (Abstract Link)<\/a><\/p>\n

63. Kalaitzidis D & TD Gilmore. 2002. Genomic organization and expression of the rearranged REL proto-oncogene in the human B-cell lymphoma cell line RC-K8. Genes, Chromosomes & Cancer 34: 129-135. (Abstract Link)<\/a><\/p>\n

64.Gapuzan M-E, P Yufit & TD Gilmore. 2002. Immortalized embryonic mouse fibroblasts lacking the RelA subunit of transcription factor NF-kB have a malignantly transformed phenotype. Oncogene 24: 2484-2492. (Abstract Link)<\/a> (Image Link<\/a>)<\/p>\n

65. Li C, S Bardhan, EA Pace, M-C Liang, TD Gilmore & JA Porco Jr. 2002. The angiogenesis inhibitor epoxyquinol A: total synthesis and inhibition of transcription factor NF-kB. Organic Letters 4: 3267-3270.\u00a0(Abstract Link)<\/a><\/p>\n

66. Kalaitzidis D, RE Davis, A Rosenwald, LM Staudt & TD Gilmore. 2002. The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel\/NF-kB signal transduction pathway. Oncogene 21: 8759-8768.\u00a0(Abstract Link)<\/a><\/p>\n

67. Gilmore TD. 2003. Rel\/NF-kB\/IkB signal transduction and cancer.\u00a0 In, Signal Transduction in Cancer<\/em> (ed. DA Frank), pp 241-265.\u00a0(Abstract Link)<\/a><\/p>\n

68. Wang Y & TD Gilmore. 2003. Zyxin and paxillin proteins: focal adhesion plaque LIM domain proteins go nuclear. Biochimica et Biophysica Acta 1593: 115-120. (Abstract Link)<\/a> (Data-link 5 — Link to full Table 1<\/a>)<\/p>\n

69.\u00a0 Gilmore TD & G Mosialos. 2003. Viruses as intruders in the Rel\/NF-kB signaling pathway.\u00a0 In, Nuclear Factor-kB: Regulation and Role in Disease<\/em> (ed. R Beyaert), Kluwer Academic Publishers, The Netherlands, pp 91-115.<\/p>\n

70.\u00a0Liang M-C, S Bardhan, C Li, EA Pace, JA Porco Jr & TD Gilmore. 2003.\u00a0 Jesterone dimer, a synthetic derivative of the fungal metabolite jesterone, blocks activation of Nuclear Factor kB by inhibiting Inhibitor of kB kinase. Molecular Pharmacology 64: 123-131.\u00a0(Abstract Link)<\/a><\/p>\n

71.\u00a0Gapuzan M-ER, GA Pitoc & TD Gilmore. 2003. Mutations within a conserved protein kinase A recognition sequence confer temperature-sensitive and partially defective activities onto mouse c-Rel. Biochemical and Biophysical Research Communications 307: 92-99. (Abstract Link)<\/a><\/p>\n

72.\u00a0Starczynowski D, JG Reynolds & TD Gilmore. 2003. Deletion of either C-terminal transactivation subdomain enhances the in vitro<\/em> transforming activity of human transcription factor REL in chicken spleen cells. Oncogene 22: 6928-6936. (Abstract Link)<\/a> (Data-link 6<\/a>)<\/p>\n

73.\u00a0 Gilmore TD, J Jean-Jacques, R Richards, C Cormier, J Kim & D Kalaitzidis. 2003. Stable expression of the avian retroviral oncoprotein v-Rel in avian, mouse, and dog cell lines. Virology 316: 9-16. (Abstract Link)<\/a><\/p>\n

74. Gilmore TD, D Kalaitzidis, M-C Liang & DT Starczynowski. 2004. The c-Rel transcription factor and B-cell proliferation: a deal with the devil. Oncogene 23: 2275-2286. (Abstract Link)<\/a><\/p>\n

75. Kalaitzidis D, J Ok, L Sulak II, D Starczynowski & TD Gilmore. 2004. Characterization of a human REL-estrogen receptor fusion protein with a reverse conditional transforming activity in chicken spleen cells. Oncogene 23: 7580-7587. (Abstract Link)<\/a> (Data Link 7<\/a>)<\/p>\n

76. Kalaitzidis D & TD Gilmore. 2005. Transcription factor cross-talk: Estrogen receptor and NF-kB. Trends in Endocrinology and Metabolism 16: 46-52. (Abstract Link)<\/a> (featured cover photo)<\/p>\n

77. Gapuzan M-ER, O Schmah, AD Pollock, A Hoffmann & TD Gilmore. 2005. Immortalized embryonic fibroblasts from NF-kB RelA knockout mice show phenotypic heterogeneity and maintain sensitivity to tumor necrosis factor alpha after transformation by v-Ras. Oncogene 24: 6574-6583. (Abstract Link)<\/a><\/p>\n

78. Starczynowski DT, JG Reynolds & TD Gilmore. 2005. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL can enhance its in vitro transforming ability. Oncogene 24: 7355-7368. (Abstract Link)<\/a> (Data Link 8<\/a>)<\/p>\n

79. Liang M-C, S Bardhan, EA Pace, D Rosman, JA Beutler, JA Porco Jr & TD Gilmore. 2006. Inhibition of transcription factor NF-kB signaling proteins IKKb and p65 through specific cysteine residues by epoxyquinone A monomer:\u00a0 correlation with its anti-cancer cell growth activity. Biochemical Pharmacology 71: 634-645. (Abstract Link)<\/a><\/p>\n

80. Liang M-C, S Bardhan, JA Porco Jr & TD Gilmore. 2006. The synthetic epoxyquinoids jesterone dimer and epoxyquinone A monomer induce apoptosis and inhibit REL (human c-Rel) DNA binding in an IkBa-deficient diffuse large B-cell lymphoma cell line. Cancer Letters 241: 69-78. (Abstract Link)<\/a><\/p>\n

81. Perkins ND & TD Gilmore. 2006. Good cop, bad cop: the different faces of NF-kB. Cell Death & Differentiation 13: 759-772. (Abstract Link)<\/a><\/p>\n

82. Gilmore TD. 2006. Introduction to NF-kB: players, pathways, perspectives. Oncogene 25: 6680-6684. (Abstract Link)<\/a><\/p>\n

83. Courtois G & TD Gilmore. 2006. Mutations in the NF-kB signaling pathway: implications for human disease. Oncogene 25: 6831-6843. (Abstract Link)<\/a><\/p>\n

84. Gilmore TD & M Herscovitch. 2006. Inhibitors of NF-kB signaling: 785 and counting. Oncogene 25: 6887-6899. (Abstract Link)<\/a><\/p>\n

85. Sullivan JC, D Kalaitzidis, TD Gilmore & JR Finnerty. 2007. Rel homology domain-containing transcription factors in the cnidarian Nematostella vectensis. Development Genes and Evolution 217: 63-72. (Abstract Link)<\/a><\/p>\n

86. Starczynowski DT, H Trautmann, C Pott, L Harder, N Arnold, JA Africa, JR Leeman, R Siebert & TD Gilmore. 2007. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL’s in vitro transforming activity. Oncogene 26: 2685-2694. (Abstract Link)<\/a> (Data Link 9<\/a>)<\/p>\n

87. Gilmore TD. 2007. Multiple myeloma: lusting for NF-kB. Cancer Cell\u00a0 12: 95-97. (Abstract Link)<\/a><\/p>\n

88. Herscovitch M, W Comb, T Ennis, K Coleman, S Yong, B Armstead, D Kalaitzidis, S Chandani & TD Gilmore. 2008. Intermolecular disulfide bond formation in the NEMO dimer requires Cys54 and Cys347. Biochemical and Biophysical Research Communications 367: 103-108. (Abstract Link)<\/a> (Data Link 10<\/a>)<\/p>\n

89. Leeman JR, MA Weniger, TF Barth & TD Gilmore. 2008. Deletion analysis and alternative splicing define a transactivation inhibitory domain in human oncoprotein REL. Oncogene 27: 6770-6781 (Abstract Link)<\/a> (Data Link 11<\/a>)<\/p>\n

90. Leeman JR & TD Gilmore. 2008. Alternative splicing in the NF-kB signaling pathway. Gene 423: 97-107. (Abstract Link)<\/a><\/p>\n

91. Garbati MR & TD Gilmore. 2008. Ser484 and Ser494 in REL are the major sites of IKK phosphorylation in vitro: evidence that IKK does not directly enhance GAL4-REL transactivation. Gene Expression 14: 195-205. (Abstract Link)<\/a> (Data Link 12<\/a>)<\/p>\n

92. Gilmore TD, ND Perkins & G Franzoso. 2009. Getting away from it all in Capri:\u00a0 The 2008 EMBO Workshop on NF-kB. Cell Death & Differentiation 16: 651-654. (Abstract Link)<\/a><\/p>\n

93. Chin M*, M Herscovitch*, N Zhang, DJ Waxman & TD Gilmore. 2009. Overexpression of an activated version of the REL oncoprotein enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile. Oncogene 28: 2100-2111. *co-first authors (Abstract Link)<\/a><\/p>\n

94. Sullivan JC, FS Wolenski, AM Reitzel, CE French, N Traylor-Knowles, TD Gilmore & JR Finnerty. 2009. Two alleles of NF-kB in the sea anemone Nematostella vectensis are widely dispersed in nature and encode proteins with distinct activities. PLoS ONE 4: e7311. doi:10.137\/journal.pone.0007311 (Paper Link)<\/a> (Abstract Link)<\/a><\/p>\n

95. Garbati MR, G Alco & TD Gilmore. 2010. Histone acetyltransferase p300\u00a0 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8. Cancer Letters 291: 237-245. (Abstract Link)<\/a> (Data Link 13<\/a>)<\/p>\n

96. Gilmore TD, RC Thompson & AC Faber. 2010. Cyclins D3 and E go hand in hand with Cdk4\/6 in diffuse large B-cell lymphoma. Cell Cycle 9: 448-449. (Abstract Link)<\/a><\/p>\n

97. Thompson RC*, M Herscovitch*, I Zhao, TJ Ford & TD Gilmore. 2011. NF-kB down-regulates expression of the B-lymphoma marker CD10 through a miR-155\/PU.1 pathway. Journal of Biological Chemistry 286: 1675-1681.\u00a0\u00a0(Abstract Link)<\/a> *co-first authors<\/p>\n

98. Garbati M, RC Thompson, L Haery & TD Gilmore. 2011. A rearranged EP300<\/em> gene in the human B-cell lymphoma cell line RC-K8 encodes a disabled transcriptional co-activator that contributes to cell growth and oncogenicity. Cancer Letters 302: 76-83. (Abstract Link)<\/a> (Data Link 14<\/a>).\u00a0 Published Erratum, in Cancer Letters (2012) 315: 96.<\/p>\n

99. Wolenski F, MR Garbati, TJ Lubinski, N Traylor-Knowles, DJ Stefanik, E Dresselhaus, H Goucher, JR Finnerty & TD Gilmore. 2011. Characterization of the core elements of the NF-kB signaling pathway of the sea anemone Nematostella vectensis<\/em>. Molecular and Cellular Biology 31: 1076-1087.\u00a0\u00a0(Abstract Link)<\/a> (featured cover photo)<\/p>\n

100. Gilmore TD & MR Garbati. 2011. Inhibition of NF-kB signaling as a strategy in disease therapy. Current Topics in Microbiology and Immunology 349:\u00a0 245-263. (Abstract Link)<\/a><\/p>\n

101. Gilmore TD & S Gerondakis. 2011. The c-Rel transcription factor in development and disease. Genes & Cancer 7: 695-711. (Abstract Link)<\/a><\/p>\n

102. Wolenski FS, S Chandani, DJ Stefanik, N Jiang, E Chu, JR Finnerty & TD Gilmore. 2011. Two polymorphic residues account for the differences in DNA binding and transcriptional activation by NF-kB proteins encoded by naturally occurring alleles in Nematostella vectensis<\/em>. Journal of Molecular Evolution 73: 325-336. (Abstract Link)<\/a><\/p>\n

103. Yeo AT, JA Porco Jr & TD Gilmore. 2012. Bcl-XL<\/sub>, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosis. Cancer Letters 318: 53-60.\u00a0 (Abstract Link)<\/a><\/p>\n

104. Gilmore TD & FS Wolenski. 2012. Evolution of NF-kB: where did it come from and why? Immunological Reviews 246: 14-35. (Abstract Link)<\/a><\/p>\n

105. Wolenski F, J Finnerty & T Gilmore. 2012. Preparation of antiserum and detection of proteins by Western blotting using the starlet sea anemone, Nematostella vectensis<\/em>. Protocol Exchange: doi<\/abbr>:10.1038\/protex.2012.057<\/p>\n

106. Wolenski FS, CA Bradham, JR Finnerty & TD Gilmore. 2013. NF-kB is required for cnidocyte development in the sea anemone Nematostella vectensis<\/em>. Developmental Biology 373: 205-215. (Abstract Link)<\/a><\/p>\n

107. Stefanik DJ, FS Wolenski, TD Gilmore & JR Finnerty. 2013.\u00a0 Isolation of DNA, RNA and protein from the starlet sea anemone Nematostella vectensis<\/em>. Nature Protocols 8: 892-899. (Abstract Link<\/a>)<\/p>\n

108. Layden MJ, E Rottinger, FS Wolenski, TD Gilmore & MQ Martindale. 2013. Microinjection techniques for reverse genetic analysis in the starlet sea anemone, Nematostella vectensis<\/em>. Nature Protocols 8: 924-934. (Abstract Link<\/a>)<\/p>\n

109. Wolenski FS, MJ Layden MQ Martindale, TD Gilmore & JR Finnerty. 2013. Characterizing the spatiotemporal expression of RNAs and proteins in the starlet sea anemone, Nematostella vectensis<\/em>. Nature Protocols 8: 900-915. (Abstract Link<\/a>)<\/p>\n

110. Gilmore TD, AM Tarrant & JR Finnerty. 2013. A report from the second Nematostella vectensis<\/em> research conference. Development Genes and Evolution 223: 207-211. (Abstract Link<\/a>)<\/p>\n

111. Thompson RC, I Vardinogiannis & TD Gilmore. 2013. The sensitivity of diffuse large B-cell lymphoma cell lines to histone deacetylase inhibitor-induced apoptosis is modulated by BCL-2 family protein activity. PLoS ONE 8: e62822 (Abstract Link<\/a>)<\/p>\n

112. Thompson RC, I Vardinogiannis & TD Gilmore. 2013. Identification of an NF-\u03baB p50-p65-responsive site in the human MIR155HG<\/i> promoter. BMC Molecular Biology 14: 24 (Abstract Link<\/a>)<\/p>\n

113. Cote SM, TD Gilmore*, R Shaffer, U Weber, R Bollam, MS Golden, K Glover, M Herscovitch, T Ennis, KN Allen & A Whitty*. 2013. Mutation of nonessential cysteines shows that the NF-\u03baB essential modulator (NEMO) forms a constitutive noncovalent dimer that binds I\u03baB kinase-\u03b2 (IKK\u03b2) with high affinity. Biochemistry 52: 9141-9154 (Abstract Link<\/a>) (Data Link) *Co-corresponding authors<\/p>\n

114. Haery L,<\/b> JG Lugo-Pic\u00f3, RA Henry, AJ Andrews, TD<\/strong> Gilmore.<\/strong> 2014. Histone acetyltransferase-deficient p300 mutants in diffuse large B-cell lymphoma have altered transcriptional regulatory activities and are required for optimal cell growth. Molecular Cancer 13: 29. (Abstract Link<\/a>) (Data Link)<\/p>\n

115. Zhou L, A Yeo, C Ballarano, U Weber, KN Allen*, TD Gilmore<\/strong>*, A Whitty*. 2014. Disulfide-mediated stabilization of the I\u03baB kinase binding domain of NF-\u03baB essential modulator (NEMO). Biochemistry 53: 7929-7944.\u00a0 *Co-corresponding authors (Abstract Link<\/a>)<\/p>\n

116. Tarrant AM, TD Gilmore<\/strong>, AM Reitzel, O Levy, U Technau, MQ Martindale. 2015. Current directions and future perspectives from the third Nematostella<\/em> research conference. Zoology\u00a0 118: 135-140. (Abstract Link<\/a>)<\/p>\n

117. Gilmore TD<\/strong>, C Gelinas. 2015. Methods for assessing the in vitro transforming activity of NF-\u03baB transcription factor c-Rel and related proteins. Methods in Molecular Biology 1280: 427-446. (Abstract Link<\/a>)<\/p>\n

118. Siggers T, TD Gilmore<\/strong>, B Barron, A Penvose. 2015. Characterizing the DNA binding site specificity of NF-\u03baB with protein binding microarrays (PBMs). Methods in Molecular Biology 1280: 609-630. (Abstract Link<\/a>)<\/p>\n

119. Finnerty JR, TD Gilmore<\/strong>. 2015. Methods for analyzing the evolutionary relationship of NF-\u03baB proteins using free, web-driven bioinformatics and phylogenetic tools. Methods in Molecular Biology 1280: 631-646. (Abstract Link<\/a>)<\/p>\n

120. Yeo AT, S Chennamadhavuni, A Whitty, JA Porco Jr, TD Gilmore<\/strong>. 2015. Inhibition of oncogenic transcription factor REL by the natural product derivative calafianin monomer 101 induces growth arrest and apoptosis in human B-lymphoma cell lines. Molecules 20: 7474-7494. (Abstract Link<\/a>)<\/p>\n

121. Haery L, RT Thompson, TD Gilmore. 2015. Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy. Genes & Cancer 6: 184-213. (Abstract Link<\/a>)<\/p>\n

122. Alshanbayeva A, A Thomas, M Tremblay, M Abbas, F Abdurrob, T Almojel, A Aparicio, D Asarpota, A Ayers, A Aziz, J Bishop, T Christie, MJM Chua, O Chung, N Dhar, A Diedrich, C Fortin, Q He, S Heerboth, R Hok, A Khedkar, S Kitchloo, C Lawlor, B Leonard, S Linderman, M Maloyan, L Miller, C Pak, A Pandita, I Park, N Patel, J Ramachandran, M Reynoso, Y Samaha, G Thole, J Turnbill, L Xia, J Zhu, C Navarro, TD Gilmore<\/strong>. 2015. N- and C-terminal non-conserved residues contribute to transactivation by a sea anemone (Nematostella vectensis<\/i>) NF-\u03baB transcription factor. BIOS 86: 165-175. (Abstract Link<\/a>)<\/p>\n

123. Haery L, S Mussakhan, DJ Waxman, TD Gilmore<\/strong>. 2016. Evidence for an oncogenic modifier role for mutant histone acetyltransferases in diffuse large B-cell lymphoma. Leukemia & Lymphoma 57: 2661-2671. (Abstract Link<\/a>)<\/p>\n

124. Cotter KA, DA Nacci, D Champlin, AT Yeo, TD Gilmore,<\/strong>\u00a0GV Callard. 2016. Adaptive significance of ER\u03b1 splice variants in killifish (Fundulus heteroclitus<\/em>) resident in an estrogenic environment. Endocrinology 157: 2294-2308. (Abstract Link<\/a>)<\/p>\n

125. Brennan JJ, JL Messerschmidt, LM Williams, BJ Matthews, M Reynoso, TD Gilmore<\/strong>. 2017. A sea anemone model has a single Toll-like receptor that can function in pathogen detection, NF-\u03baB signal transduction, and development. Proceedings of the National Academy of Sciences USA 114: E10122-E10131<\/span> (Abstract Link<\/a>)<\/p>\n

126. Mansfield KM, NM Carter, L Nguyen,, A Alshanbayeva, LM Williams, C Crowder, AR Penvose, JR Finnerty, VM Weis, TW Siggers, TD Gilmore<\/strong>. 2017. Conserved transcription factor NF-\u03baB is modulated by symbiotic status in a sea anemone model for cnidarian bleaching. Scientific Reports 7: 16025. (Abstract Link<\/a>)<\/p>\n

127. Williams LM, LE Fuess, JJ Brennan, KM Mansfield, E Salas-Rodriguez, J Welsh, J Awtry, S Banic, C Chacko, A Chezian, <\/span>D Dowers, F Estrada, Y-H Hsieh, J Kang, W Li, Z Malchiodi, J Malinowski, S Matuszak, T McTigue IV, D Mueller, B Nguyen, M Nguyen, P Nguyen, S Nguyen, N Njoku, K Patel, W Pelligrini, T Pliakas, D Qadir, E Ryan, A Schiffer, A Thiel, V Weis, SA Yunes, KE Spilios, JH Pinz\u00f3n C, LD Mydlarz, TD Gilmore<\/strong>. 2018. A conserved Toll-like receptor-to-NF-\u03baB signaling pathway in the endangered coral Orbicella faveolata. <\/em>Developmental & Comparative Immunology 79: 128-136 (Abstract Link<\/a>)<\/p>\n

128. Friedman LE, TD Gilmore,<\/strong>\u00a0JR Finnerty. 2018. Intraspecific variation in peroxide sensitivity in the starlet sea anemone Nematostella vectensis<\/em>, an estuarine cnidarian. PLoS ONE\u00a013: e0188265 (Abstract Link<\/a>)<\/p>\n

129. Brennan JJ, TD Gilmore<\/strong>. 2018. Evolutionary origins of Toll-like receptor signaling. Molecular Biology and Evolution 35: 1576-1587\u00a0 (Abstract Link<\/a>)<\/p>\n

130. Mansfield KM, TD Gilmore<\/strong>. 2019.\u00a0Innate immunity and cnidarian-Symbiodiniaceae mutualism. Developmental & Comparative Immunology 90: 199-209 (Abstract Link<\/a>)<\/p>\n

131. Shaffer R, AH DeMaria, L Kagermazova, Y Liu, M Babaei, S Caban-Penix, A Cernates, S Jehle, L Makowski,, TD Gilmore<\/strong>, A Whitty, KN Allen. 2019. A central conserved region of NEMO is required for IKK\u03b2-induced conformational change and signal propagation. Biochemistry 58: 2906-2920 (Abstract Link<\/a>)<\/p>\n

132. Babaei M*, YK Liu*, SM Wuerzberger-Davis, EZ McCaslin, CJ DiRusso, AT Yeo, L Kagermazova, S Miyamoto, TD Gilmore<\/strong>. 2019. CRISPR\/Cas9-based editing of a sensitive transcriptional regulatory element to achieve cell type-specific knockdown of the NEMO scaffold protein. PLoS ONE\u00a014:e0222588 (Paper Link<\/a>)\u00a0 (preprint at bioRxiv, doi:<\/span> https:\/\/doi.org\/10.1101\/450320 ) <\/span><\/a>*co-first authors<\/p>\n

133. Williams <\/sup>LM, MM Inge, KM Mansfield, A Rasmussen, J Afghan, M Agrba, C Albert, N Andersson, M Babaei, M Babaei, A Bagdasaryants, A Bonilla, A Browne, S Carpenter, T Chen, B Christie, A Cyr, K Dam, N Dulock, G <\/span>Erdene, L <\/span>Esau, S Esonwune, A Hanchate, X Huang, T Jennings, A Kasabwala,<\/span> L Kehoe, R Kobayashi, M Lee, A LeVan, Y Liu, E Murphy, A Nambiar, M Olive, D Patel, F Pavesi, CA Petty, Y Samofalova, S Sanchez, C Stejskal, Y Tang, A Yapo, JP Cleary, SA Yunes, T Siggers, TD Gilmore<\/strong>. 2020. Transcription factor NF-\u03baB in a basal metazoan, the sponge, has conserved and unique sequences, activities, and regulation.\u00a0Develomnental & Comparative Immunology 104:103599. (Abstract Link<\/a>)\u00a0(<\/em>preprint at\u00a0bioRxiv<\/em> http:\/\/biorxiv.org\/cgi\/content\/short\/691097v1)<\/a><\/p>\n

134. Williams LM,\u00a0TD Gilmore<\/strong>. 2020. Looking down on NF-\u03baB. Molecular and Cellular Biology 40:\u00a0 e00104-20. (Abstract Link<\/a>)<\/p>\n

135. Mansfield KM, PA Cleves, E Van Vlack, NG Kriefall, BE Benson, DJ Camacho, O Hemond, M Pedroza, T Siggers, JR PRingle, SW Davies*, TD Gilmore<\/strong>*. 2019. Varied effects of algal symbionts on transcription factor NF-\u03baB in a sea anemone and a coral: possible roles in symbiosis and thermotolerance. bioRxiv<\/em>, doi:<\/span><\/a>\u00a0https:\/\/doi.org\/10.1101\/640177\u00a0<\/span>*co-corresponding authors<\/p>\n

136. Aguirre Carri\u00f3n PJ*, LM Williams*, TD Gilmore<\/strong>. 2020. Molecular and biochemical approaches to study the evolution of NF-\u03baB signaling in basal metazoans. Methods in Molecular Biology 2366: 67-91. *co-first authors (Abstract Link<\/a>)<\/p>\n

137. Gilmore TD<\/strong>. 2021. NF-\u03baB and human cancer: what have we learned over the past 35 years? Biomedicines 9: 889 (Abstract Link<\/a>)<\/p>\n

138. Williams LM, S Sridhar, J Samaroo, J Peart, EK Adindu, A Addanki, CJ DiRusso, BB522 Molecular Biology Laboratory, PJ Aguirre Carri\u00f3n,<\/span> N Rodriguez Sastre,\u00a0T Siggers, TD Gilmore<\/strong>. 2021. Comparison of NF-\u03baB from the protists Capsaspora\u00a0owczarzaki<\/span><\/em> and\u00a0Acanthoeca spectabilis<\/em> reveals extensive evolutionary diversification of this transcription factor. <\/span>Communications Biology 4: 1404 (Abstract link) (preprint on bioRxi <\/em>at https:\/\/biorxiv.org\/cgi\/content\/short\/2021.03.15.435342v1<\/a>)<\/p>\n

139. Williams LM, TD Gilmore<\/strong>. 2022. An innate ability: how do basal invertebrates manage their chronic exposure to microbes? PLoS Pathogens e: 1010897 (Abstract Link<\/a>) (Paper Link<\/a>)<\/p>\n

140. DiRusso CJ, M Dhastiahangar, TD Gilmore<\/strong>. 2022. Scaffold proteins as dynamic integrators of biological processes. Journal of Biological Chemistry 298: 102628 (Paper link<\/a>) (Abstract link<\/a>)<\/p>\n

141. Aguirre Carri\u00f3n PJ, N Desai, JJ Brennan, J Fifer, T Siggers, SW Davies, TD Gilmore<\/strong>. 2023. Starvation decreases immunity and immune regulatory factor NF-\u03baB in the starlet sea anemone Nematostella vectensis<\/em>. Communications Biology 6: 695 (Paper Link<\/a>) (preprint on bioRxiv at https:\/\/biorxiv.org\/cgi\/content\/short\/2022.06.09.495518v1<\/a>)<\/p>\n

142. DiRusso CJ*, AM DeMaria*, J Wong, W Wang, JJ Jordanides, A Whitty, KN Allen**, TD Gilmore<\/strong>**. 2023. A conserved core region of the scaffold NEMO is essential for a signal-induced conformational change and liquid-liquid phase separation. Journal of Biological Chemistry 99: 105396\u00a0 (Paper Link<\/a>) *Co-first authors; **Co-corresponding authors (preprint of this article at bioRxiv<\/em> https:\/\/www.biorxiv.org\/content\/10.1101\/2023.05.25.542299v1<\/a>)<\/strong><\/p>\n

143. Valadez-Ingersoll M, PJ Aguirre Carri\u00f3n PJ, C Bodnar, NA Desai, TD Gilmore<\/strong>**, SW Davies**. 2024. Starvation differentially affects gene expression, immunity, and pathogen susceptibility across symbiotic states in a model cnidarian. Proceedings of the Royal Academy B: Biological Sciences 291: 20231685 **Co-corresponding authors (Abstract link<\/a>) (preprint of this article at bioRxiv <\/em>(https:\/\/www.biorxiv.org\/content\/10.1101\/2023.07.30.551141v1<\/a>)<\/strong><\/p>\n

144. Inge MM*, R Miller*, H Hook, D Bray, JL Keenan, R Zhao, TD Gilmore<\/strong>, T Siggers. 2024. Rapid profiling of transcription factor-cofactor interaction networks reveals principles of epigenetic regulation. Nucleic Acids Research 52:10276-10296 (Abstract link<\/a>) *Co-first authors (preprint on bioRxiv<\/em> at https:\/\/www.biorxiv.org\/content\/10.1101\/2024.04.05.588333v1<\/span><\/a>)<\/p>\n

145. Wang MR, M Valadez-Ingersoll, TD Gilmore<\/strong>. 2024. Control of nuclear localization of the nucleocapsid protein of SARS-CoV-2. Virology 600:110232 (Abstract link<\/a>)<\/span><\/p>\n

146. Da-Anoy JK, K Toyama, O Jasnos, A Wong, TD Gilmore<\/strong>, SW Davies. 2025. Antibiotic treatment and microbiome depletion slow cnidarian regeneration. Integrative and Comparative Biology, Mar 11:icaf007<\/span> (Abstract Link<\/a>) (preprint on bioRxiv <\/em>at https:\/\/www.biorxiv.org\/content\/10.1101\/2024.11.24.625057v2)<\/p>\n

147. Valadez-Ingersoll M, Rivera HE, Da-Anoy J, Kanke MR, Gomez-Campo K, Martinez-Rugeiro MI, Metz S, Sweet M, Kwan J, Hekman R, Emili A, TD Gilmore<\/strong>**, SW Davies**. 2025. Cell type-specific immune regulation under symbiosis in a facultatively symbiotic coral.<\/em> The ISME Journal 19: wraf132 **Co-corresponding authors\u00a0 (Paper Link<\/a>) (preprint on bioRxiv at https:\/\/www.biorxiv.org\/content\/10.1101\/2024.06.20.599951v1<\/a>)<\/p>\n

148. Bouadi O, C Yao, J Zeng, D Beason, N Inda, Z Malone, J Yoshihara, A Vinayak Manjally, M Johnson III, J Cherry, C-Y Chin, T-C Huang, B Popovic, M Henley, G Liu, E Kharitonova, E Zeldich, H Aichelman, SW Davies, P Walentek, Y Tian, H Man, E Ozsen, K Harder, TD Gilmore<\/strong>, D Pitta, T Leng Tay. 2025. AutoMor Fi: automated whole-image morphometry in Fiji\/Imagej for diverse image analysis needs. Nature Methods, in preparation (preprint on bioRxiv<\/em> at https:\/\/doi.org\/10.1101\/2024.07.26.605357<\/a>)<\/p>\n

149. Williams <\/sup>LM*, W Wang, A Grigoryeva, A Navarro-Rosado, J Peart, A Calderon, C Gill, S Black, K Alsante, A Lackstrom, Molecular Biology Laboratory, B Weissbourd, M Wang, CJ DiRusso, L Cohen, Z Wunderlich, BP Grone, TD Gilmore*<\/strong>. 2025. Comparison of activities of transcription factor NF-\u03baB from two jellyfish models. Comparative Immunology Reports 9: 200232 *Co-first authors (Paper Link<\/a>) (preprint on bioRxiv <\/em>at https:\/\/doi.org\/10.1101\/2025.01.21.634164)<\/p>\n

150. Valadez-Ingersoll M, CA Bodnar, EX Feng, A Wong, TD Gilmore<\/strong>, SW Davies. 2026. Symbiotic state affects microbiome recovery in a facultatively symbiotic cnidarian. Scientific Reports 25: 11026 (Abstract Link<\/a>).\u00a0 Preprint on bioRxiv at https:\/\/www.biorxiv.org\/content\/10.1101\/2025.11.04.686571v1<\/a><\/p>\n

151. Glass BH, T Abraham, T Siggers, SW Davies, TD Gilmore<\/strong>. 2026. NF-\u03baB: a diverse and multifunctional transcription factor in Holozoans. Molecular Biology and Evolution 43: msag059 (Abstract Link<\/a>)\u00a0 (Paper Link<\/a>)<\/p>\n

152. Glass BH, HE Aichelman, CGB Grupstra, M Valadez-Ingersoll, A Swank, V Guerra, P Gondola, A Nagree, J Schipfer, TD Gilmore<\/strong>, SW Davies. 2026. Legacy effects of an extreme marine heatwave on a stress-tolerant coral. Global Change Biology 32: e70853 (Paper Link<\/a>)<\/p>\n

153. Da-Anoy J, M-H Chen, A Bouchie, J Dougherty, A Lapadula, A Skena, W Wang, T Abraham, KR Thompson, O Jasnow, KS, Toyama, J Ayivor, O Diya, TD Gilmore<\/strong>, SW Davies. 2026 Algae-specific immune modulation influences response to heat and pathogen challenge in a symbiotic coral. Science Advances, in press. Preprint on bioRxiv at \u00a0https:\/\/www.biorxiv.org\/cgi\/content\/short\/2025.11.05.684850v1<\/a><\/p>\n

154. Glass BH, TD Gilmore<\/strong>, SW Davies. 2026. Cool and warm conditions disrupt development through divergent mechanisms in larvae of the reef-building coral Orbicella faveolata. <\/em>BMC Genomics, in review<\/p>\n

155. Glass BH, J Da-Anoy, KG Jones, TD Gilmore<\/strong>, SW Davies. 2026. The sea anemone Nematostella vectensis<\/em> as a versatile model species in ecophysiology: a review and further directions. Journal of Experimental Biology, in review<\/p>\n

Published Letters to Editor<\/strong><\/p>\n

1. Gilmore TD. 1997. Don’t overlook oncoprotein Rel. Journal of NIH Research 9: 14-16.<\/p>\n

2. White DW & TD Gilmore. 1997. Transcription factors, oncogenes, and apoptosis. Science (reviewed letter) 276: 185. (Abstract Link)<\/a><\/p>\n

3. Gilmore TD, DT Starczynowski & D Kalaitzidis. 2004. REL<\/em>evant gene amplification in B-cell lymphomas? Blood (reviewed letter) 103: 3243. (Abstract Link)<\/a><\/p>\n

Encyclopedia Entries <\/strong><\/p>\n

1. Gilmore TD. 2001. Rel. In, Encyclopedia of Molecular Medicine<\/em>. John Wiley & Sons, New York, NY. Volume 3, pp 2752-2754.<\/p>\n

2. Gilmore TD. 2001. Rel. In, Encyclopedic Reference of Cancer<\/em> (M Schwab, editor). Springer-Verlag Publishers, Heidelberg, Germany. pp 761-764.<\/p>\n

3. Gilmore TD. 2004 (updated 2013). Nuclear Factor kappaB. In, Encyclopedia of Biological Chemistry<\/em> (WJ Lennarz & MD Lane, editors). Elsevier, Oxford, UK. Volume 3, pp 302-305.<\/p>\n

4. Gilmore TD & YT Ip. 2009. Signal transduction pathways in development and immunity:\u00a0 NFkB\/Rel pathways. (Version 3.0). In, Encyclopedia of Life Sciences<\/em>, John Wiley & Sons, Ltd. Chichester, UK. http:\/\/www.els.net\/<\/a> [Doi 10.1002\/9780470016902.a0002332.pub3]\u00a0\u00a0 <\/a><\/p>\n

5. Gilmore TD. 2008. Rel. In, Encyclopedia of Cancer, 2nd Edition<\/em> (M Schwab, editor). Springer-Verlag Publishers, Heidelberg, Germany.<\/p>\n

6. Gilmore TD. 2011. Rel. In, Encyclopedia of Cancer, 3rd Edition<\/em> (M Schwab, editor). Springer-Verlag Publishers, Heidelberg, Germany.<\/p>\n

7. Gilmore TD. 2013. Rel oncogene. In, Brenner’s Online Encyclopedia of Genetics, 2nd Edition<\/em> (S Malloy, K Hughes, editors). Elsevier, New York.\u00a0 Vol 6, pp 126-128.<\/p>\n

8. Gilmore TD, TW Siggers & S Gerondakis. 2016. NF-kappaB and the immune system. In, Encyclopedia of Cell Biology <\/i>(RA Bradshaw, PD Stahl, eds) Waltham, MA. Volume 3: Functional Cell Biology, pp 580-587.<\/p>\n

9. Gilmore TD.<\/strong> 2017. Rel. In, <\/span>Encyclopedia of Cancer, 4th Edition <\/em>(M Schwab, ed.) Springer-Verlag Publishers, Heidelberg, Germany.<\/span><\/p>\n

10. Gilmore TD*,<\/strong> T Siggers. 2023. NF-kappaB and the immune system. In, Encyclopedia of Cell Biology, Second Edition <\/em>(RA Bradshaw, GW Hart, PD Stahl eds). Volume 5: 417-426 Oxford, Elsevier *Corresponding author<\/p>\n

11. Gilmore TD.<\/strong> 2021. NF-\u03baB and human cancer. In, E Scholarly Community Encyclopedia<\/em>, MDPI publishers https:\/\/encyclopedia.pub\/18757<\/a><\/p>\n

12. Gilmore TD.<\/strong> 2024. Rel oncogene. In, Reference Module in Life Sciences. <\/em>Elsevier,<\/span> New York.ISBN 9780128096338,. https:\/\/doi.org\/10.1016\/B978-0-12-822563-9.00220-1<\/a>.<\/span><\/p>\n

 <\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

  1. Radke K, T Gilmore, GS Martin. 1980. Phosphorylation of a 36,000 molecular weight cellular polypeptide in Rous sarcoma virus-transformed fibroblasts. In, Protein Phosphorylation and Bio-Regulation (eds. G Thomas, E Podesta, and J Gordon), S Karger, Basel, Switzerland, pp 186-192. 2.Radke K, T Gilmore,\u00a0GS Martin. 1980. Transformation by Rous sarcoma virus: a cellular substrate […]<\/p>\n","protected":false},"author":4258,"featured_media":0,"parent":337,"menu_order":4,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"_links":{"self":[{"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/pages\/192"}],"collection":[{"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/users\/4258"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/comments?post=192"}],"version-history":[{"count":50,"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/pages\/192\/revisions"}],"predecessor-version":[{"id":1414,"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/pages\/192\/revisions\/1414"}],"up":[{"embeddable":true,"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/pages\/337"}],"wp:attachment":[{"href":"https:\/\/www.bu.edu\/nf-kb\/wp-json\/wp\/v2\/media?parent=192"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}